Loading…
SkinHealth Systems Inc. is projected to decline to $0.6998 by 2027, a -11% move from its current price of $0.7836. SKIN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.7352 | $0.7828 | $0.8334 | -0.10% |
| May 30 | $0.7156 | $0.782 | $0.8545 | -0.21% |
| May 31 | $0.7008 | $0.7812 | $0.8708 | -0.31% |
| Jun 1 | $0.6884 | $0.7804 | $0.8846 | -0.41% |
| Jun 2 | $0.6776 | $0.7795 | $0.8969 | -0.52% |
| Jun 3 | $0.6679 | $0.7787 | $0.908 | -0.62% |
| Jun 4 | $0.659 | $0.7779 | $0.9183 | -0.72% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.659 | $0.7779 | $0.9183 | -0.72% |
| Week 2 | $0.6108 | $0.7723 | $0.9765 | -1.44% |
| Week 3 | $0.5752 | $0.7667 | $1.02 | -2.16% |
| Week 4 | $0.5463 | $0.7611 | $1.06 | -2.87% |
| Week 5 | $0.5215 | $0.7556 | $1.09 | -3.57% |
| Week 6 | $0.4997 | $0.7502 | $1.13 | -4.27% |
| Week 7 | $0.4802 | $0.7447 | $1.16 | -4.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SkinHealth Systems Inc. is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions across the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. Its flagship HydraFacial enhances the skin to cleanse, extract, and hydrate with proprietary solutions and serums.
It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc.
in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SkinHealth Systems Inc. (SKIN) is a Consumer Defensive stock with a current price of $0.7836 and a market capitalization of $101.55M. It is currently ranked 4176 by market cap among listed assets.
The 2026 forecast shows an average price of $0.7836 with 0% ROI and neutral sentiment. Looking beyond 2026, the forecast highlights upside potential, with bullish momentum emerging in 2030 (avg $1.05, max $1.83, min $0.6464, ROI 34.2%) and continuing toward higher levels by 2050 (avg $2.62, max $6.03, min $1.18, ROI 234.3%). This suggests a path from a near-term, stable outlook to a longer-term bullish trajectory, though outcomes are not guaranteed.
A major floor 50.5% below — a decisive break under it would weaken the trend.
The nearest floor, 26.0% below — buyers have tended to step in here.
The nearest ceiling, 23.8% above — a clean break opens room to run.
A major ceiling 99.1% above — clearing it would confirm fresh momentum.
Key SKIN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SKIN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7336 | Buy | $0.75 | Buy |
| MA 10 | $0.6908 | Buy | $0.729 | Buy |
| MA 20 | $0.7477 | Buy | $0.7513 | Buy |
| MA 50 | $0.8679 | Sell | $0.8615 | Sell |
| MA 100 | $1.07 | Sell | $1.02 | Sell |
| MA 200 | $1.39 | Sell | $1.24 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.57 | Neutral |
| Stoch RSI (14) | 79.81 | Neutral |
| CCI (20) | 22.54 | Neutral |
| Williams %R (14) | -38.18 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 35.17 | Buy |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 61.82 | Neutral |
| TRIX (15) | -1.07 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 56.98 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | -8.00 | Sell |
| Hull MA (9) | 0.79 | Sell |
| ADX (14) | 18.50 | Neutral |
| ATR (14) | 0.05 | Info |
The near-term technical picture is NEUTRAL. The RSI(14) sits at 50, with the 50-day simple moving average at $0.8679 and the 200-day simple moving average at $1.39. These moving averages indicate a lack of strong immediate momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.58 | $0.7836 | $1.02 | 0% | Neutral | |
| $0.5036 | $0.6998 | $1.05 | -11% | Neutral | |
| $0.4166 | $0.6144 | $0.9821 | -22% | Bearish | |
| $0.4691 | $0.7282 | $1.22 | -7% | Neutral | |
| $0.6464 | $1.05 | $1.83 | +34% | Bullish | |
| $0.5674 | $0.9642 | $1.74 | +23% | Bullish | |
| $0.5371 | $0.9518 | $1.77 | +21% | Bullish | |
| $0.5443 | $1.00 | $1.92 | +28% | Bullish | |
| $0.417 | $0.8005 | $1.57 | +2% | Neutral | |
| $0.5027 | $1.00 | $2.01 | +28% | Bullish | |
| $0.4762 | $1.06 | $2.33 | +35% | Bullish | |
| $1.18 | $2.62 | $6.03 | +234% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.58 | $0.7836 | $0.9325 | +0.00% |
| June 2026 | $0.6394 | $0.7668 | $0.9529 | -2.14% |
| July 2026 | $0.5844 | $0.7128 | $0.9085 | -7.04% |
| August 2026 | $0.5851 | $0.7232 | $0.9397 | +1.46% |
| September 2026 | $0.6109 | $0.7634 | $1.01 | +5.56% |
| October 2026 | $0.5873 | $0.7415 | $0.9923 | -2.87% |
| November 2026 | $0.5599 | $0.7134 | $0.9663 | -3.80% |
| December 2026 | $0.5777 | $0.7425 | $1.02 | +4.08% |
Click any year to see its month-by-month SKIN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SKIN price prediction for 2026 points to an average of $0.7836 (low $0.58, high $1.02) — a potential gain of 0% on today's $0.7836. Price action looks broadly range-bound.
In 2027, SKIN is projected to trade between $0.5036 and $1.05, averaging $0.6998 — a potential decline of -11% from today's $0.7836. That is -11% versus the projected 2026 average. A consolidation phase looks the most probable path here.
SkinHealth Systems Inc.'s 2028 outlook centres on $0.6144, within a $0.4166 to $0.9821 range. That is -12% versus the projected 2027 average. That marks a -22% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2029, SKIN could reach as high as $1.22, with a base case around $0.7282 and support toward $0.4691 — roughly -7% from $0.7836. A consolidation phase looks the most probable path here.
Expect SKIN to range from $0.6464 to $1.83 through 2030. The $1.05 average target implies a +34% move from current prices. That is up +44% on the projected 2029 average. Momentum favours further upside here.
The SKIN price prediction for 2031 points to an average of $0.9642 (low $0.5674, high $1.74) — a potential gain of +23% on today's $0.7836. Buyers look set to stay in control over this stretch.
In 2032, SKIN is projected to trade between $0.5371 and $1.77, averaging $0.9518 — a potential gain of +21% from today's $0.7836. That is -1% versus the projected 2031 average. Momentum favours further upside here.
SkinHealth Systems Inc.'s 2033 outlook centres on $1.00, within a $0.5443 to $1.92 range. That is up +6% on the projected 2032 average. That marks a +28% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, SKIN could reach as high as $1.57, with a base case around $0.8005 and support toward $0.417 — roughly +2% from $0.7836. Price action looks broadly range-bound.
Expect SKIN to range from $0.5027 to $2.01 through 2035. The $1.00 average target implies a +28% move from current prices. That is up +25% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The SKIN price prediction for 2040 points to an average of $1.06 (low $0.4762, high $2.33) — a potential gain of +35% on today's $0.7836. Momentum favours further upside here.
In 2050, SKIN is projected to trade between $1.18 and $6.03, averaging $2.62 — a potential gain of +234% from today's $0.7836. That is up +148% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SKIN today (≈ 1,276.161307 SKIN) could be worth
$3,343.46
+$2,343.46 (+234%) by 2050 · US Dollar
Based on the average projected SKIN price of $2.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SKINwould be worth at today's price.
$1,000 invested in SKIN on May 27, 2025 (≈ 591.715956 SKIN) would be worth
$463.67
-$536.33 (-53.6%) today · 0.46× · US Dollar
Based on a SKIN entry price of $1.69 vs. today's $0.7836.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.678 | $1,155.75 | +15.6% |
| 1 month ago | $0.881 | $889.44 | -11.1% |
| 3 months ago | $0.972 | $806.17 | -19.4% |
| 6 months ago | $1.48 | $529.46 | -47.1% |
| 1 year ago | $1.69 | $463.67 | -53.6% |
| All time (5.0y) ago | $15.08 | $51.96 | -94.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SKIN forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $207.36M
The multi-year forecast shows a bullish tone developing from 2030 onward. In 2030, the forecasted average price is $1.05 with a max of $1.83 and a min of $0.6464, yielding a 34.2% ROI and a BULLISH sentiment. In 2040, the average is $1.06 with a max of $2.33 and a min of $0.4762, yielding a 35% ROI and a BULLISH sentiment.
By 2050, the average is $2.62 with a max of $6.03 and a min of $1.18, yielding a 234.3% ROI and a BULLISH sentiment. These figures point to meaningful upside potential over the long run, though the years in between show varying outcomes (e.g., 2028 min $0.4166, avg $0.6144, max $0.9821; 2029 min $0.4691, avg $0.7282, max $1.22) and are not guarantees. Investors should consider the inherent uncertainty in any forecast and the possibility of downside risk even as the longer horizon appears favorable.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.05 with a max of $1.83 and a min of $0.6464, for a ROI of 34.2% and a BULLISH sentiment.
Forecasts indicate a bullish sentiment starting in 2030 with rising prices and a high upside by 2050 (avg $2.62, max $6.03; ROI 234.3). Near term years show neutral to mixed results, so outcomes are not guaranteed and risk remains.
Yes. The 2035 forecast lists a max of $2.01, and the 2040 forecast lists a max of $2.33, indicating the $2.00 level is within the modeled upside in the mid-to-late 2020s and early 2040s.
The sentiment is NEUTRAL with RSI(14) at 50. The SMA(50) is $0.8679 and the SMA(200) is $1.39. Support is at $0.58 and resistance at $0.97. The 30-day range runs from $0.5183 to $1.18, and annualized volatility is 100%.
SkinHealth Systems Inc. Community Discussion
0Share your SkinHealth Systems Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.